ARDX
Ardelyx Inc
Price:  
5.48 
USD
Volume:  
2,519,954.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Ardelyx EV/EBITDA

-151.4%
Upside

As of 2026-03-29, the EV/EBITDA ratio of Ardelyx Inc (ARDX) is -39.47. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Ardelyx's latest enterprise value is 1,478.81 mil USD. Ardelyx's TTM EBITDA according to its financial statements is -37.47 mil USD. Dividing these 2 quantities gives us the above Ardelyx EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 11.1x - 14.0x 13.9x
Forward P/E multiples 13.7x - 18.1x 15.8x
Fair Price (2.64) - (2.69) (2.82)
Upside -148.2% - -149.1% -151.4%
5.48 USD
Stock Price
(2.82) USD
Fair Price

Ardelyx EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-03-24 -38.62
2026-03-23 -38.35
2026-03-20 -38.35
2026-03-19 -39.60
2026-03-18 -39.93
2026-03-17 -41.76
2026-03-16 -41.82
2026-03-13 -41.43
2026-03-12 -40.65
2026-03-11 -42.81
2026-03-10 -43.66
2026-03-09 -43.98
2026-03-06 -44.11
2026-03-05 -44.64
2026-03-04 -47.13
2026-03-03 -44.31
2026-03-02 -45.95
2026-02-27 -46.47
2026-02-26 -46.99
2026-02-25 -46.54
2026-02-24 -46.54
2026-02-23 -41.23
2026-02-20 -41.10
2026-02-19 -47.71
2026-02-18 -47.58
2026-02-17 -47.85
2026-02-13 -48.57
2026-02-12 -49.48
2026-02-11 -51.12
2026-02-10 -51.38
2026-02-09 -51.58
2026-02-06 -51.51
2026-02-05 -49.42
2026-02-04 -51.90
2026-02-03 -54.26
2026-02-02 -54.59
2026-01-30 -53.93
2026-01-29 -54.98
2026-01-28 -55.05
2026-01-27 -55.24
2026-01-26 -54.65
2026-01-23 -54.46
2026-01-22 -55.50
2026-01-21 -55.90
2026-01-20 -54.39
2026-01-16 -47.78
2026-01-15 -49.68
2026-01-14 -48.70
2026-01-13 -49.68
2026-01-12 -51.77